Dr. Subulade Ademola

Education

• Ph.D., Cell Biology and Genetics, University of Ibadan, Nigeria
• M.Sc., Zoology (Cell Biology and Genetics); University of Ibadan, Nigeria
• B.Tech., Pure and Applied Biology; Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria

Specialty

Molecular biology, human genetics, malaria genetics, immunogenetics, malaria, Type 2 diabetes

Professional Interests

Dr. Ademola obtained a Ph.D. in cell biology and genetics from the University of Ibadan in 2012. Over the years, she had undergone training in international institutions like Wellcome Genome Campus in the United Kingdom, Stockholm University in Sweden, and the Medical Research Council.

Dr. Ademola has an interest in the genetic basis of human diseases, both infectious and noninfectious. While she has interests in human genes and how they interact to determine the outcome of diseases, she has a keen interest in the area of immunogenetics — the genetics of immune response to diseases.

Dr. Ademola’s long term goal is focused on how immune genes interact with the social environment and the effect of such interactions on disease outcome, with the understanding that interactions between genetic, behavioral, and social factors determine disease outcome. Some of her publications are among the very few publications on the immunogenetics of infectious diseases, specifically malaria, in Africa.

Other Interests

Dr. Ademola enjoys spending time with her family, singing, reading and traveling. She plays badminton.

Recent Publications

• Taiwo H. Olajide, Yemi R. Raji, Subulade A. Ademola, Temiloluwa Dele-Alimi, Abimbola Oluwaseye, Ojetola Ayomide, Halimah O. Ajani, Mutiat A. Abdulkareem, Olukemi K. Amodu (2023). “Association between variants on the vitamin D Receptor gene and chronic kidney disease among a Yoruba population in Ibadan, Nigeria.” Human Gene 35 (2023) 201146.
• Bamikole, O.J., Olajide,T.H., Adedeji, B.A., Ademola, S.A., Fayehun, A.F., Bukoye, N.O., Olufeagba, M.B., Amodu, O.K (2023). “Drug Use Practices and Self-Treatment for Suspected Malaria in Ibadan, Nigeria.” American Journal of Tropical Medicine and Hygiene, doi:10.4269/ajtmh.22-0489.
• Ademola, S.A., Bamikole, O.J and Amodu, O.K (2023). “Is TNF alpha a mediator in the co-existence of malaria and Type 2 diabetes in a malaria endemic population?” Frontiers in Immunology. 14:1028303. doi: 10.3389/fimmu.2023.102830
• Bamikole, O.J; Ademola S.A; Dibia, A; Yellow, S.I; Etim, J; Ajige, A; Amodu, O.K (2022). “Genetic variability (785A > G, 516G > T and 64C > T) in the CYP2B6 gene among individuals in Southwest Nigeria: Implications for malaria treatment.” Human Gene 34, 201104.
• Band G, Si Le Q, Clarke GM, Kivinen K, Hubbart C, Jeffreys AE, Leffler EM, Jallow, J, Conway DJ, Sisay-Joof F, Umberto d’Alessandro SG, Toure OB, Thera MA, Konate S, Sissoko S, Mangano VD, Bougouma EC, Sirima SB, Amenga-Etego LN, Ghansah AK, Hodgson AVO, Wilson MD, Enimil A, Ansong D, Evans J, Ademola SA, Apinjoh TO, Ndila CM, Manjurano A, Drakeley C, Reyburn H, Phu NH, Quyen TN, Thai CQ, Hien TT, Teo YY, Manning L, Laman M, Michon P, Karunajeewa H, Siba P, Allen A, Bahlo M, Davis TME, Simpson V, Shelton J, Spencer CCA, Busby GBJ, Kerasidou A, Drury E, Stalker J, Dilthey A, Mentzer AJ, McVean G, Bojang KA, Doumbo O, Modiano D, Koram KA, Agbenyega T, Amodu K, Achidi E, Williams TN, Marsh K, Riley EM, Molyneux M, Taylor T, Dunstan SJ, Farrar J, Mueller I, Kirk A, Rockett K, Kwiatkowski DP.(2019). “Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania.” Nature Communications; 10: 5732.
• Amodu, O.K; Shah, B; Ademola S.A; Tayo, O.B; Gordeuk, V.R (2019). “Relationship of Host Genetic Factors with Severe Malaria in Nigerian Children.” Blood 134. Supplement 1:942. DOI: 10.1182/blood-2019-132190.

Contact Dr. Subulade Ademola

(478) 301-2707
ademola_s@mercer.edu
Office: Godsey Science Center, Room 334